Cyto-KIK: A phase II trial of cytoreductive surgery in kidney cancer plus immunotherapy (nivolumab) and targeted kinase inhibition (cabozantinib). Background: The majority of non- prostate ...

Source: Getty Images Clinicians need to familiarize themselves with menopause genitourinary symptom management so they can address the pressing medical needs of millions of women. The GSM guideline ...

TAMPA, Fla. — Patient-reported outcomes are important indicators of how cancer drugs impact patients’ lives. By assessing the benefits and risks of drugs from a patient’s perspective, scientists and ...

Despite a trend toward more patient-centered research, quality-of-life end points remain substantially underreported in phase ...

Palliative care (PC) plays a critical role in managing the difficulties associated with genitourinary malignancies. Its primary aim is to improve the overall health of patients, provide support to ...

PROEAS graph reporting the different PROEAS scores per category for randomized clinical trials individualized by GU tumor type. Abbreviations: PROEAS: Patient Reported Outcome Endpoint Analysis Score; ...